According to the FDA’s draft guidelines, companies wanting to make a generic version of Restasis have two options – an in vitro study or an in vivo study. The first option implies that no clinical ...

If you have chronic (long-term) dry eye, your doctor might suggest treatment with Xiidra or Restasis. They’re both prescription medications prescribed to treat chronic dry eye (also called dry eye ...

Aurinia Pharmaceuticals has presented a mixed bag of midphase data on its challenger to Allergan’s blockbuster dry eye drug Restasis. The challenger, VOS, failed to better the tolerability of Restasis ...

Restasis is a brand-name eye drop that’s prescribed for chronic dry eye. The medication is available in single-use and multiuse vials. Restasis is a type of immunosuppressant. Restasis is approved by ...

Please provide your email address to receive an email when new articles are posted on . IRVINE, Calif. — The recent Food and Drug Administration approval of the dry eye drug Restasis (cyclosporine ...

Restasis is the second largest Allergan's franchise and it's likely to slow down in 2017 for the competition of Xiidra. The institution of Mylan's IPR litigation by PTAB has increased the chances of ...